US-based company is developing next-generation sequencers, using AI models in the Republic to speed up diagnostics and lower ...

Illumina, Inc., a global genomics and human health leader innovating the future of precision health, announced the launch of BioInsight, a new business within Illumina, developed to meet industry ...

Shares of genomics company Illumina (NASDAQ:ILMN) jumped 6.6% in the afternoon session after the company announced the launch of BioInsight, a new business unit designed to accelerate drug discovery ...

SAN DIEGO, Oct. 1, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced the launch of BioInsight, a new business within Illumina, developed to meet industry demand for deeper biologic ...

Sept 22 (Reuters) - Life sciences company Element Biosciences sued Illumina (ILMN.O), opens new tab on Monday in separate cases in federal courts in California and ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. SAN DIEGO — A year ago, Illumina CEO Jacob Thaysen laid out a plan for the genomics ...

With Illumina's divestiture of GRAIL, the company will improve its operating expenses, since GRAIL reported significant losses while it was part of Illumina. The global DNA sequencing market is ...

Somiya Adrees is a writer at GameRant. Her gaming journey began at a young age with classics like Super Mario Bros., Sonic the Hedgehog, and Disney's Aladdin in Nasira's Revenge (all of which she ...

Less than two years after Boulder-based biotech firm SomaLogic Inc. merged with Standard BioTools Inc. (Nasdaq: LAB), Illumina Inc. (NASDAQ: ILMN) has inked a deal to absorb SomaLogic’s business in an ...

Illumina is diving deeper into proteomics research with a $425 million plan to acquire SomaLogic, including its protein analysis platforms and certified lab services business. The deal with ...

Illumina faces significant challenges, including revenue declines, margin pressures, and geopolitical hurdles, notably from China and competition from Roche's SBX technology. Q1 2025 results were in ...

Illumina lowered its annual financial forecast and says it plans to cut about $100 million in costs after China banned imports of its gene sequencers last week. The San Diego maker of gene-sequencing ...